Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 6Breast 2Other hematologic neoplasm 1Lymphoid 1Endocrine 1

Conditions

Multiple Endocrine Neoplasia Type 1 5Obesity 4Motor Activity 2Sexual Dysfunction, Physiological 1Overweight 1Limb-girdle muscular dystrophy, type 2C 1Inflammation 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1

Interventions

Sucrose 1Exercise 1Diet 1Aspartame 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Overweight × Exercise × Endocrine × Clear all
NCT05311800 2023-02-24

RIESLING

Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques

Phase NA Completed
9 enrolled
EndocrineOther

Obesity, Multiple Endocrine Neoplasia Type 1, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡